AVE's Principal Activity is the development, production, sale and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skin care and animal health and nutrition industries.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | +13.31% |
vs ASX 200 (1yr) | +6.11% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Avecho Biotechnology Limited (AVE, formerly Phosphagenics Limited) is into developing and commercialising products containing its TPM technology. Each of the business divisions, Production, Human Health, and Animal Health and Nutrition have progressed with the common goal of advancing commercialisation of products containing the Company's TPM technology.
Incorporated in VIC on 19/06/1992 as Greenchip Development Capital Ltd. Name changed to Vital Capital Limited on 27/04/1999. Name changed to Phosphagenics Limited on 10/2/2004. Changed GICS from 4020 Diversified Financials to 3520 Pharmaceuticals & Biotechnology on 4/3/2005.
Head Office | Clayton VIC 3168 |
Website | www.avecho.com.au |
Registry | Computershare |
Auditor | Grant Thornton Audit Pty Ltd |
Date Listed | 11 Aug 1993 |
Date | Event |
---|---|
23/08/2022 | Report (Interim) |
27/02/2023 | Report (Prelim) |
27/02/2023 | Report (Annual) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Key Data | |
---|---|
DPS(TTM) | $0.00 |
Gross DPS(TTM) | $0.00 |
Dividend yield |
|
Gross yield |
|
Payout Ratio | -- |
DRP | No |
DRP Features | - |
AVE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of AVE directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Mark Gregory KERR | 03/02/2022 | 199,503,526 | 10.91 |
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2021 | $0.016 | 30 June |
2020 | $0.007 | 30 June |
2019 | $0.003 | 28 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.